These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 9188571)
1. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins. Johnson JE; Schnell MJ; Buonocore L; Rose JK J Virol; 1997 Jul; 71(7):5060-8. PubMed ID: 9188571 [TBL] [Abstract][Full Text] [Related]
2. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Schnell MJ; Buonocore L; Kretzschmar E; Johnson E; Rose JK Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11359-65. PubMed ID: 8876140 [TBL] [Abstract][Full Text] [Related]
3. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Haglund K; Forman J; Kräusslich HG; Rose JK Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333 [TBL] [Abstract][Full Text] [Related]
4. Insertion of the human immunodeficiency virus CD4 receptor into the envelope of vesicular stomatitis virus particles. Schubert M; Joshi B; Blondel D; Harmison GG J Virol; 1992 Mar; 66(3):1579-89. PubMed ID: 1310767 [TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. Owens RJ; Rose JK J Virol; 1993 Jan; 67(1):360-5. PubMed ID: 8093220 [TBL] [Abstract][Full Text] [Related]
6. Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. Boritz E; Gerlach J; Johnson JE; Rose JK J Virol; 1999 Aug; 73(8):6937-45. PubMed ID: 10400792 [TBL] [Abstract][Full Text] [Related]
7. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions. Johnson JE; Rodgers W; Rose JK Virology; 1998 Nov; 251(2):244-52. PubMed ID: 9837788 [TBL] [Abstract][Full Text] [Related]
8. Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. Buonocore L; Blight KJ; Rice CM; Rose JK J Virol; 2002 Jul; 76(14):6865-72. PubMed ID: 12072487 [TBL] [Abstract][Full Text] [Related]
9. Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia. Betancourt D; Ramos JC; Barber GN J Virol; 2015 Dec; 89(23):11786-800. PubMed ID: 26378177 [TBL] [Abstract][Full Text] [Related]
10. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Kahn JS; Schnell MJ; Buonocore L; Rose JK Virology; 1999 Feb; 254(1):81-91. PubMed ID: 9927576 [TBL] [Abstract][Full Text] [Related]
11. Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus. Lagging LM; Meyer K; Owens RJ; Ray R J Virol; 1998 May; 72(5):3539-46. PubMed ID: 9557633 [TBL] [Abstract][Full Text] [Related]
12. Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1. Rose NF; Roberts A; Buonocore L; Rose JK J Virol; 2000 Dec; 74(23):10903-10. PubMed ID: 11069984 [TBL] [Abstract][Full Text] [Related]
13. Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus. Schnell MJ; Buonocore L; Boritz E; Ghosh HP; Chernish R; Rose JK EMBO J; 1998 Aug; 17(5):1289-96. PubMed ID: 9482726 [TBL] [Abstract][Full Text] [Related]
15. High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. Kretzschmar E; Buonocore L; Schnell MJ; Rose JK J Virol; 1997 Aug; 71(8):5982-9. PubMed ID: 9223488 [TBL] [Abstract][Full Text] [Related]
16. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Bartz SR; Vodicka MA Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614 [TBL] [Abstract][Full Text] [Related]
17. Expression and processing of human immunodeficiency virus type 1 gp160 using the vesicular stomatitis virus New Jersey serotype vector system. Wu K; Kim GN; Kang CY J Gen Virol; 2009 May; 90(Pt 5):1135-1140. PubMed ID: 19264597 [TBL] [Abstract][Full Text] [Related]
18. Induction of Tier 1 HIV Neutralizing Antibodies by Envelope Trimers Incorporated into a Replication Competent Vesicular Stomatitis Virus Vector. Bresk CA; Hofer T; Wilmschen S; Krismer M; Beierfuß A; Effantin G; Weissenhorn W; Hogan MJ; Jordan APO; Gelman RS; Montefiori DC; Liao HX; Schmitz JE; Haynes BF; von Laer D; Kimpel J Viruses; 2019 Feb; 11(2):. PubMed ID: 30769947 [TBL] [Abstract][Full Text] [Related]